117 related articles for article (PubMed ID: 38703793)
21. Characterization of graded 6-Hydroxydopamine unilateral lesion in medial forebrain bundle of mice.
Cui J; Zhao D; Xu M; Li Z; Qian J; Song N; Wang J; Xie J
Sci Rep; 2024 Feb; 14(1):3721. PubMed ID: 38355892
[TBL] [Abstract][Full Text] [Related]
22. Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Lee EY; Lee JE; Park JH; Shin IC; Koh HC
Toxicol Lett; 2012 Sep; 213(3):332-44. PubMed ID: 22842585
[TBL] [Abstract][Full Text] [Related]
23. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.
Kikuchi Y; Yasuhara T; Agari T; Kondo A; Kuramoto S; Kameda M; Kadota T; Baba T; Tajiri N; Wang F; Tayra JT; Liang H; Miyoshi Y; Borlongan CV; Date I
J Cell Physiol; 2011 May; 226(5):1390-8. PubMed ID: 20945350
[TBL] [Abstract][Full Text] [Related]
24. Early post-treatment with 9-cis retinoic acid reduces neurodegeneration of dopaminergic neurons in a rat model of Parkinson's disease.
Yin LH; Shen H; Diaz-Ruiz O; Bäckman CM; Bae E; Yu SJ; Wang Y
BMC Neurosci; 2012 Oct; 13():120. PubMed ID: 23040108
[TBL] [Abstract][Full Text] [Related]
25. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
[TBL] [Abstract][Full Text] [Related]
26. Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis.
Toti L; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G1013-23. PubMed ID: 25277799
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of RET and GDNF family receptor, GFR-α1, between striatum and substantia nigra following nigrostriatal lesion: A case for diminished GDNF-signaling.
Kasanga EA; Han Y; Navarrete W; McManus R; Shifflet MK; Parry C; Barahona A; Manfredsson FP; Nejtek VA; Richardson JR; Salvatore MF
Exp Neurol; 2023 Aug; 366():114435. PubMed ID: 37178997
[TBL] [Abstract][Full Text] [Related]
28. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection.
O'Dell SJ; Gross NB; Fricks AN; Casiano BD; Nguyen TB; Marshall JF
Neuroscience; 2007 Feb; 144(3):1141-51. PubMed ID: 17157992
[TBL] [Abstract][Full Text] [Related]
29. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model.
Jamali-Raeufy N; Mojarrab Z; Baluchnejadmojarad T; Roghani M; Fahanik-Babaei J; Goudarzi M
Metab Brain Dis; 2020 Mar; 35(3):539-548. PubMed ID: 32016817
[TBL] [Abstract][Full Text] [Related]
30. Differential sensitivity of cranial and limb motor function to nigrostriatal dopamine depletion.
Plowman EK; Maling N; Rivera BJ; Larson K; Thomas NJ; Fowler SC; Manfredsson FP; Shrivastav R; Kleim JA
Behav Brain Res; 2013 Jan; 237():157-63. PubMed ID: 23018122
[TBL] [Abstract][Full Text] [Related]
31. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
[TBL] [Abstract][Full Text] [Related]
32. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
33. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
[TBL] [Abstract][Full Text] [Related]
34. Acupuncture prevents 6-hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model.
Park HJ; Lim S; Joo WS; Yin CS; Lee HS; Lee HJ; Seo JC; Leem K; Son YS; Kim YJ; Kim CJ; Kim YS; Chung JH
Exp Neurol; 2003 Mar; 180(1):93-8. PubMed ID: 12668152
[TBL] [Abstract][Full Text] [Related]
35. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
Rosenblad C; Kirik D; Björklund A
Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
[TBL] [Abstract][Full Text] [Related]
36. DJ-1 protein protects dopaminergic neurons against 6-OHDA/MG-132-induced neurotoxicity in rats.
Sun SY; An CN; Pu XP
Brain Res Bull; 2012 Sep; 88(6):609-16. PubMed ID: 22664331
[TBL] [Abstract][Full Text] [Related]
37. The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: A neurochemical, immunohistochemical and behavioral study.
Bharatiya R; Bratzu J; Lobina C; Corda G; Cocco C; De Deurwaerdere P; Argiolas A; Melis MR; Sanna F
Behav Brain Res; 2020 Apr; 384():112562. PubMed ID: 32070689
[TBL] [Abstract][Full Text] [Related]
38. Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease.
Stenslik MJ; Potts LF; Sonne JW; Cass WA; Turchan-Cholewo J; Pomerleau F; Huettl P; Ai Y; Gash DM; Gerhardt GA; Bradley LH
J Neurosci Methods; 2015 Aug; 251():120-9. PubMed ID: 25999268
[TBL] [Abstract][Full Text] [Related]
39. Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease.
Ambrosi G; Armentero MT; Levandis G; Bramanti P; Nappi G; Blandini F
Brain Res Bull; 2010 Apr; 82(1-2):29-38. PubMed ID: 20100549
[TBL] [Abstract][Full Text] [Related]
40. Chronic Treatment with the Probiotics Lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 Attenuates Motor Impairment, Striatal Microglial Activation, and Dopaminergic Loss in Rats with 6-Hydroxydopamine-induced Hemiparkinsonism.
Cuevas-Carbonell SG; Vásquez-Celaya L; García-López D; Granados-Patrón D; García-Miss MDR; Álvarez-Cervera FJ; Mut-Martín M; Parra I; Mendieta L; Salgado H; Alamilla J; Cruz-Bojórquez R; Ávila-Escalante ML; Aranda-González II; Góngora-Alfaro JL
Neuroscience; 2022 Dec; 507():79-98. PubMed ID: 36370934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
